Xeljanz: An Effective Treatment for Rheumatoid Arthritis and Ulcerative Colitis Xeljanz (tofacitinib) is a medication used to treat rheumatoid arthritis (RA) and ulcerative colitis (UC). It is manufactured and sold by Pfizer Inc. Xeljanz is available in two dosages, 5mg and 10mg, and comes in tablet form. The medication works by reducing inflammation in the body, which can ease the symptoms of RA and UC. Uses Xeljanz is primarily used to treat RA and UC. RA is a chronic autoimmune disorder that causes inflammation and pain in the joints, and can lead to joint damage. UC is an inflammatory bowel disease that causes inflammation of the colon and rectum, leading to pain, diarrhea and fever. Xeljanz helps to relieve the symptoms of these conditions and improve quality of life for patients. Dosage The recommended dosage of Xeljanz for RA is 5mg twice daily. For UC, the recommended dosage is 10mg twice daily for 8 weeks, followed by 5mg twice daily. The dosage may be adjusted based on the patient's response to the medication and any side effects they may experience. It is important to follow the dosage instructions provided by the prescribing physician and not make any changes without consulting them first. Demographic Xeljanz is approved for use in adults aged 18 years and older with RA and UC. It is not recommended for use in children or adolescents. The medication can be taken by both males and females. Side Effects Xeljanz may cause side effects in some patients. The most common side effects reported include upper respiratory tract infections, headaches, diarrhea, and nausea. Other potential side effects include an increased risk of infections, liver damage, and an increased risk of certain cancers. It is important to speak with a healthcare provider about any potential risks and benefits of treatment with Xeljanz. Interactions Xeljanz may interact with other medications, including antifungal medications, immunosuppressants, and live vaccines. Patients should inform their healthcare provider of any medications they are taking, including over-the-counter medications, supplements, and herbal remedies, to avoid potential interactions. Generic Options There are currently no generic versions of Xeljanz available on the market. The medication is protected by patents held by Pfizer Inc. In conclusion, Xeljanz is a medication used to treat rheumatoid arthritis and ulcerative colitis. It works by reducing inflammation in the body and can provide relief for patients with these conditions. Xeljanz is available in two dosages and may cause side effects in some patients. It is important to speak with a healthcare provider about any potential risks or benefits of treatment with Xeljanz, as well as any other medications being taken. There are currently no generic versions of Xeljanz available.